rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

IQVIA Holdings, Inc.

IQV · NYSE

Health CareLife-science toolsLeading

IQV stood above a rising 150-day average in 25 of the last 52 weekly readings, including each of the last 11 weeks. It is 31.1% above that average now. Life Science Tools & Research Services: 48% of its 79 stocks in an uptrend (−5 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
11 in a row
Industry in uptrend
48% -5 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$81.2M
Officials’ trades on record
42
Institutions holding
1,021 (+17)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 25 of 52 weeks.

23 Apr – 22 Oct
28%42%57%Apr 26Jun 26Jul 26Sep 26Oct 26

Life-science tools: About half its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$53.8M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

42 disclosed lines: House 28, Senate 8, executive 6; 13 people.

WhoDidAmountTraded
Kevin Hern House: U.S. House ClerkOK01soldjoint$15k–$50k14 Sep 2026filed 25 Sep 2026
Kevin Hern House: U.S. House ClerkOK01solddependent child$1k–$15k8 Sep 2026filed 25 Sep 2026
Kevin Hern House: U.S. House ClerkOK01solddependent child$1k–$15k3 Sep 2026filed 25 Sep 2026
Markwayne Mullin Executive branch: Office of Government EthicsDepartment of Homeland Securitysold$50k–$100k18 May 2026filed 25 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k27 Apr 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k10 Apr 2026filed 1 Jul 2026
Kevin Hern House: U.S. House ClerkOK01soldjoint$50k–$100k16 Mar 2026filed 3 Apr 2026
Markwayne Mullin Senate: U.S. Senate eFDSenatorboughtjoint$15k–$50k29 Dec 2025filed 16 Jan 2026
John Boozman Senate: U.S. Senate eFDSenatorsold part ofjoint$1k–$15k2 Oct 2025filed 15 Nov 2025
Robert P. Bresnahan, Jr. House: U.S. House ClerkPA08sold$1k–$15k15 May 2025filed 31 May 2025
Robert P. Bresnahan, Jr. House: U.S. House ClerkPA08bought$15k–$50k8 Apr 2025filed 8 May 2025
Robert P. Bresnahan, Jr. House: U.S. House ClerkPA08sold$1k–$15k25 Feb 2025filed 27 Mar 2025

Insiders

Buy orders, 12 months0
Sale orders, 12 months9
Buyers · sellers0 · 6
WhoDidSharesTraded
James G. BerkshireOfficersold2,668at $261.332 Sep 2026filed 4 Sep 2026
W. Richard StaubOfficersold5,500at $232.683 Aug 2026filed 4 Aug 2026
Bhavik PatelOfficersold1,855at $235.2731 Jul 2026filed 4 Aug 2026
Ari BousbibDirector, Officersold4,465at $247.1029 Jul 2026filed 31 Jul 2026
Ari BousbibDirector, Officersold4,584at $246.8529 Jul 2026filed 31 Jul 2026
Ari BousbibDirector, Officersold44,039at $246.0829 Jul 2026filed 31 Jul 2026
Ari BousbibDirector, Officersold53,191at $244.7829 Jul 2026filed 31 Jul 2026
Keriann CherofskyOfficersold558at $245.2129 Jul 2026filed 31 Jul 2026
Eric SherbetOfficersold5,000at $249.1629 Jul 2026filed 31 Jul 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders1,021+17 on the quarter
New · exited135 · 118
Reported value$29.5B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.reduced · filed 7 Aug 202614,549,693$2.8B-477,751−3.2%
HARRIS ASSOCIATES L Padded · filed 14 Aug 202612,183,830$2.4B+5550.0%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 202610,905,053$2.1B-121,930−1.1%
STATE STREET CORPadded · filed 7 Aug 20267,508,244$1.5B+31,282+0.4%
VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 20267,501,993$1.4B-74,008−1.0%
JPMORGAN CHASE & COnew · filed 12 Aug 20266,139,775$1.2B+6,139,775
Artisan Partners Limited Partnershipreduced · filed 13 Aug 20264,743,434$916.5M-315,431−6.2%
Boston Partnersadded · filed 4 Aug 20264,466,016$865.5M+227,058+5.4%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 20264,454,134$857.2M-8,918−0.2%
Invesco Ltd.added · filed 14 Aug 20263,275,141$632.8M+13,363+0.4%
31 Mar 2023 – 30 Jun 2026
7789201062Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Kevin Hern HouseOK01 · last 14 Sep 20265 · 5
James G. Berkshire Company insiderOfficer · last 2 Sep 20260 · 1
W. Richard Staub Company insiderOfficer · last 3 Aug 20260 · 5
Bhavik Patel Company insiderOfficer · last 31 Jul 20260 · 1
Ari Bousbib Company insiderDirector, Officer · last 29 Jul 20260 · 21
Eric Sherbet Company insiderOfficer · last 29 Jul 20260 · 6
Keriann Cherofsky Company insiderOfficer · last 29 Jul 20260 · 2
Colleen A. Goggins Company insiderDirector · last 14 Jul 20260 · 0
Jim Fasano Company insiderDirector · last 14 Jul 20260 · 0
John G. Danhakl Company insiderDirector · last 14 Jul 20263 · 9
Morris Leslie Wims Company insiderDirector · last 14 Jul 20260 · 0
Markwayne Mullin Executive branchDepartment of Homeland Security · last 18 May 20263 · 1

Same industry

OABI OmniAbLeading+67%
TXG 10x GenomicsLeading+55%
AVTR AvantorLeading+51%
ILMN IlluminaLeading+45%
RVTY RevvityLeading+39%
SDGR SchrodingerLeading+30%
MASS 908 DevicesLeading+29%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Operating profit marginFY 2025 · to 31 Dec 202513.4%
Free cash flow marginFY 2025 · to 31 Dec 202512.6%
Return on capital employedFY 2025 · to 31 Dec 202510.1%
Cash conversionFY 2025 · to 31 Dec 2025195%
Debt to equityFY 2025 · to 31 Dec 20252.42×
Interest coverFY 2025 · to 31 Dec 20252.99×
Share count trendFY 2025 · to 6 Feb 20260.1%
Cash and equivalentsFY 2025 · to 31 Dec 2025$2.0B
Free cash flowFY 2025 · to 31 Dec 2025$2.1B

Analyst forecasts

No analyst forecasts yet.